Approaches to hyperactivate T cells with drugs are largely played out unless applied to very specific patient populations selected by molecular criteria.

“so anyway just trying to hyperactivate T cells um with drugs I would say we've we've kind of played that out it's hard to imagine the only way to revolutionize that would be what I just alluded to which is really like really kind of tightening um or or sharpening our lens if you will um and focusing on on applying those drugs in very specific patient populations”